Solan: DCA Under Lens As Drug Firm Didn’t Disclose Buyer Details

Solan: The working of the Drug Control Administration (DCA), Baddi, has come under the scanner as despite large-scale sale of psychotropic drugs in the last one year, the management of Biogenetic Drugs Private Limited failed to disclose details of the buyers to the authorities, violating the conditions of the grant of licence.

The state DCA yesterday froze raw material of psychotropic drugs found at the company premises for its failure to disclose details of the sale of such drugs in around a year.

Information on the stock of raw material as well as psychotropic drugs like alprazolam and codeine found at the premises revealed that the company had been mostly producing only these drugs. Since these drugs are mainly misused by drug abusers, their large-scale production — running into crores of tablets per year — has put a question mark over the operations of this unit, which has been operational since 2005.

Had the Punjab’s Special Task Force not exposed the sales record, it’s debatable whether the SDA would have been able to get a sniff into such suspicious activities.

The company has been issued a three-day notice to disclose its sales record, and its laxity could attract cancellation of its product approval, said State Drugs Controller Manish Kapoor.

According to the probing authorities, the company management is supposed to provide details of the quantity of drugs dispatched, address of purchaser, batch number as well as the sales amount to the drug inspector, state drugs controller and the Superintendent of Police at the time the drugs are dispatched from the company premises.

Sources say that the company had manufactured 21.66 crore alprazolam 0.5 tablets, under various brands, since May 6, 2023.

They had purchased 139 kg of alprazolam as raw material since May 2023, while 40 kg was the stock in hand. It was taken into possession by the Punjab STF under provisions of the Narcotic Drugs and Psychotropic Substances Act.

Apart from this, more than 400 kg of codeine raw material was found on the premises. Alprazolam tablets numbering 1.97 crore were stocked at the manufacturing unit.

“The stock of psychotropic drugs and its raw material like codeine, alprazolam, etc, found on the company premises has been frozen as long as the departmental probe is underway. The management has been issued a three-day notice to respond to the queries regarding the issues raised by the STF, apart from other violations of the non-disclosure of drug sales,” informed Manish Kapoor.

Related Posts

Puresta launches EVERQ, AI-powered skin-health platform

Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre

US FDA launches expedited IND Pilot, begins accepting applications

US FDA launches expedited IND Pilot, begins accepting applications

PIL in SC seeks time-bound probe, stringent action against fake drug networks

PIL in SC seeks time-bound probe, stringent action against fake drug networks

Ghaziabad: Fake supplement racket busted, 5 held

Ghaziabad: Fake supplement racket busted, 5 held

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records